Word: merck
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Botswana government hired McKinsey to help design an AIDS-treatment program--a critical need in a country where 300,000 people out of a population of 1.6 million are infected with HIV. Darkoh volunteered to draw up the program and presented it to the Botswana leadership. With funding from Merck and the Gates Foundation, the government brought him to the capital, Gaborone, where he set up shop. What Darkoh found when he arrived was a population not only ravaged by AIDS but also seemingly numb to its horrors. "Someone would come into work and say his brother died," Darkoh says...
...Professor of Medicine Jerome L. Avorn.Avorn said that he could find no explanation for Gaziano’s ideas, as expressed in court. “You’d have to ask him that yourself,” said Avorn. “The evidence is incontrovertible. Merck [the company that manufactures Vioxx] itself admitted that it found a doubling of heart attack and stroke in Vioxx users in a randomized trial it conducted. That’s why it took the drug off the market.”Gaziano, a cardiologist who has never done Vioxx research, said...
...HORIZON: THE FIRST CANCER VACCINE A large-scale trial found Merck's experimental vaccine Gardasil 100% effective against two strains of human papillomavirus thought to cause 70% of all cervical cancers. If FDA approved, it may arrive...
...nothing else, analysts say, the verdict constitutes a stern rebuke to Big Pharma. Jurors heard plenty from the plaintiff's lawyers about Merck's aggressive sales and marketing tactics and about a corporate culture that, they claimed, prizes profits over honest science. Merck, however, is hardly alone in being accused of such things. Wyeth, for one, has set aside $21 billion to pay for claims stemming from fen-phen, its faulty diet-drug combo. Analysts estimate that Merck could be on the hook for more than $18 billion in Vioxx damages...
...Merck investors may take comfort in the fact that jackpot jury awards are often reduced on appeal. Texas law caps punitive damages, and the final award probably won't exceed $26.1 million. Merck not only plans to appeal in Texas but also has vowed to continue fighting each Vioxx claim individually. Ailing as it is, the firm is expected to generate $3.5 billion in cash this year. In other words, Merck isn't going bankrupt tomorrow. Which is just what the trial lawyers like to hear. --By Daren Fonda